The Medicines Evaluation Board (MEB) is responsible for the authorization and supervision of medicines on the market in the Netherlands. The MEB assesses the quality, efficacy and safety of (herbal) medicines for humans and animals and the safety of novel foods. In addition, the MEB invests in improving information on medicines for health care providers and patients and conducts scientific research in the field of “Regulatory Science” (see our Science Policy for our main topics). Scientific data form the basis for the legal tasks at the MEB, and the scientific analysis of data is an important basis for our assessments of medicines. The MEB does all this in the interests of public health.